iRadimed Corporation
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving iRadimed Corporation now
Current reporting with the operating signal separated from the noise.
IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference
The story matters when it changes iRadimed Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.What makes Iradimed Corporation (IRMD) a compelling opportunity?
The story matters when it changes iRadimed Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Is There Now An Opportunity In IRADIMED CORPORATION (NASDAQ:IRMD)?
The story matters when it changes iRadimed Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.IRADIMED CORPORATION (IRMD) Q3 2025 Earnings Call Transcript
Investors are testing whether iRadimed Corporation’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
Investors are testing whether iRadimed Corporation’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.This Insider Has Just Sold Shares In IRadimed Corporation (NASDAQ:IRMD)
Investors are testing whether iRadimed Corporation’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.IRadimed Corporation (NASDAQ:IRMD) insiders sold US$1.0m worth of stock suggesting impending weakness.
Investors are testing whether iRadimed Corporation’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest IRMD filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
iRadimed Corporation, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
SEARCH Q2 COVERAGE →Third quarter
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →